Logo image of FFARM.AS

FORFARMERS NV (FFARM.AS) Stock Fundamental Analysis

Europe - AMS:FFARM - NL0011832811 - Common Stock

4.535 EUR
+0.02 (+0.33%)
Last: 10/7/2025, 4:10:45 PM
Fundamental Rating

6

Taking everything into account, FFARM scores 6 out of 10 in our fundamental rating. FFARM was compared to 58 industry peers in the Food Products industry. FFARM has an average financial health and profitability rating. FFARM is valued quite cheap, while showing a decent growth score. This is a good combination! This makes FFARM very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year FFARM was profitable.
In the past year FFARM had a positive cash flow from operations.
FFARM had positive earnings in 4 of the past 5 years.
Each year in the past 5 years FFARM had a positive operating cash flow.
FFARM.AS Yearly Net Income VS EBIT VS OCF VS FCFFFARM.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

The Return On Assets of FFARM (4.86%) is better than 67.24% of its industry peers.
The Return On Equity of FFARM (15.59%) is better than 82.76% of its industry peers.
The Return On Invested Capital of FFARM (9.72%) is better than 82.76% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for FFARM is below the industry average of 7.47%.
The last Return On Invested Capital (9.72%) for FFARM is above the 3 year average (4.52%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.86%
ROE 15.59%
ROIC 9.72%
ROA(3y)1.66%
ROA(5y)1.6%
ROE(3y)4.87%
ROE(5y)4.38%
ROIC(3y)4.52%
ROIC(5y)5.03%
FFARM.AS Yearly ROA, ROE, ROICFFARM.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

FFARM has a Profit Margin of 1.72%. This is in the lower half of the industry: FFARM underperforms 65.52% of its industry peers.
FFARM's Profit Margin has improved in the last couple of years.
FFARM has a worse Operating Margin (2.47%) than 68.97% of its industry peers.
In the last couple of years the Operating Margin of FFARM has remained more or less at the same level.
With a Gross Margin value of 18.91%, FFARM is not doing good in the industry: 79.31% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of FFARM has remained more or less at the same level.
Industry RankSector Rank
OM 2.47%
PM (TTM) 1.72%
GM 18.91%
OM growth 3Y22.91%
OM growth 5Y-1.24%
PM growth 3Y36.41%
PM growth 5Y9.73%
GM growth 3Y4.94%
GM growth 5Y1.08%
FFARM.AS Yearly Profit, Operating, Gross MarginsFFARM.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), FFARM is creating some value.
FFARM has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for FFARM has been reduced compared to 5 years ago.
Compared to 1 year ago, FFARM has a worse debt to assets ratio.
FFARM.AS Yearly Shares OutstandingFFARM.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
FFARM.AS Yearly Total Debt VS Total AssetsFFARM.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

FFARM has an Altman-Z score of 3.69. This indicates that FFARM is financially healthy and has little risk of bankruptcy at the moment.
FFARM's Altman-Z score of 3.69 is amongst the best of the industry. FFARM outperforms 86.21% of its industry peers.
FFARM has a debt to FCF ratio of 2.61. This is a good value and a sign of high solvency as FFARM would need 2.61 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 2.61, FFARM belongs to the best of the industry, outperforming 87.93% of the companies in the same industry.
A Debt/Equity ratio of 0.33 indicates that FFARM is not too dependend on debt financing.
FFARM has a better Debt to Equity ratio (0.33) than 74.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 2.61
Altman-Z 3.69
ROIC/WACC1.46
WACC6.65%
FFARM.AS Yearly LT Debt VS Equity VS FCFFFARM.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.10 indicates that FFARM should not have too much problems paying its short term obligations.
FFARM has a worse Current ratio (1.10) than 65.52% of its industry peers.
FFARM has a Quick Ratio of 1.10. This is a bad value and indicates that FFARM is not financially healthy enough and could expect problems in meeting its short term obligations.
FFARM has a Quick ratio of 0.81. This is comparable to the rest of the industry: FFARM outperforms 44.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.81
FFARM.AS Yearly Current Assets VS Current LiabilitesFFARM.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

FFARM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 171.25%, which is quite impressive.
The Earnings Per Share has been growing by 14.71% on average over the past years. This is quite good.
Looking at the last year, FFARM shows a quite strong growth in Revenue. The Revenue has grown by 8.76% in the last year.
The Revenue has been growing slightly by 2.20% on average over the past years.
EPS 1Y (TTM)171.25%
EPS 3Y40.88%
EPS 5Y14.71%
EPS Q2Q%440%
Revenue 1Y (TTM)8.76%
Revenue growth 3Y0.93%
Revenue growth 5Y2.2%
Sales Q2Q%15.97%

3.2 Future

FFARM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.03% yearly.
The Revenue is expected to grow by 5.13% on average over the next years.
EPS Next Y117.81%
EPS Next 2Y51.7%
EPS Next 3Y32.03%
EPS Next 5YN/A
Revenue Next Year16.61%
Revenue Next 2Y6.93%
Revenue Next 3Y5.13%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FFARM.AS Yearly Revenue VS EstimatesFFARM.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
FFARM.AS Yearly EPS VS EstimatesFFARM.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

9

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.25 indicates a reasonable valuation of FFARM.
Based on the Price/Earnings ratio, FFARM is valued cheaper than 86.21% of the companies in the same industry.
FFARM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.90.
A Price/Forward Earnings ratio of 7.86 indicates a rather cheap valuation of FFARM.
86.21% of the companies in the same industry are more expensive than FFARM, based on the Price/Forward Earnings ratio.
FFARM is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.36, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.25
Fwd PE 7.86
FFARM.AS Price Earnings VS Forward Price EarningsFFARM.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

89.66% of the companies in the same industry are more expensive than FFARM, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, FFARM is valued cheaper than 89.66% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.15
EV/EBITDA 3.83
FFARM.AS Per share dataFFARM.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

FFARM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of FFARM may justify a higher PE ratio.
A more expensive valuation may be justified as FFARM's earnings are expected to grow with 32.03% in the coming years.
PEG (NY)0.07
PEG (5Y)0.56
EPS Next 2Y51.7%
EPS Next 3Y32.03%

6

5. Dividend

5.1 Amount

FFARM has a Yearly Dividend Yield of 4.42%, which is a nice return.
Compared to an average industry Dividend Yield of 3.35, FFARM pays a better dividend. On top of this FFARM pays more dividend than 81.03% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, FFARM pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.42%

5.2 History

The dividend of FFARM decreases each year by -12.97%.
Dividend Growth(5Y)-12.97%
Div Incr Years1
Div Non Decr Years1
FFARM.AS Yearly Dividends per shareFFARM.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

FFARM pays out 41.76% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP41.76%
EPS Next 2Y51.7%
EPS Next 3Y32.03%
FFARM.AS Yearly Income VS Free CF VS DividendFFARM.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M
FFARM.AS Dividend Payout.FFARM.AS Dividend Payout, showing the Payout Ratio.FFARM.AS Dividend Payout.PayoutRetained Earnings

FORFARMERS NV

AMS:FFARM (10/7/2025, 4:10:45 PM)

4.535

+0.02 (+0.33%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-07 2025-08-07
Earnings (Next)11-06 2025-11-06
Inst Owners3.42%
Inst Owner ChangeN/A
Ins Owners5.48%
Ins Owner ChangeN/A
Market Cap404.88M
Analysts86
Price Target5.94 (30.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.42%
Yearly Dividend0.15
Dividend Growth(5Y)-12.97%
DP41.76%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)23.5%
PT rev (3m)34.94%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)6%
EPS NY rev (3m)27.71%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3.59%
Revenue NY rev (3m)8.99%
Valuation
Industry RankSector Rank
PE 8.25
Fwd PE 7.86
P/S 0.14
P/FCF 6.15
P/OCF 3.73
P/B 1.24
P/tB 1.9
EV/EBITDA 3.83
EPS(TTM)0.55
EY12.13%
EPS(NY)0.58
Fwd EY12.72%
FCF(TTM)0.74
FCFY16.25%
OCF(TTM)1.22
OCFY26.8%
SpS33.18
BVpS3.66
TBVpS2.39
PEG (NY)0.07
PEG (5Y)0.56
Profitability
Industry RankSector Rank
ROA 4.86%
ROE 15.59%
ROCE 12.33%
ROIC 9.72%
ROICexc 10.81%
ROICexgc 13.66%
OM 2.47%
PM (TTM) 1.72%
GM 18.91%
FCFM 2.22%
ROA(3y)1.66%
ROA(5y)1.6%
ROE(3y)4.87%
ROE(5y)4.38%
ROIC(3y)4.52%
ROIC(5y)5.03%
ROICexc(3y)5.02%
ROICexc(5y)6.01%
ROICexgc(3y)6.45%
ROICexgc(5y)7.81%
ROCE(3y)5.89%
ROCE(5y)6.6%
ROICexcg growth 3Y23.14%
ROICexcg growth 5Y0.01%
ROICexc growth 3Y22.42%
ROICexc growth 5Y1.04%
OM growth 3Y22.91%
OM growth 5Y-1.24%
PM growth 3Y36.41%
PM growth 5Y9.73%
GM growth 3Y4.94%
GM growth 5Y1.08%
F-Score7
Asset Turnover2.82
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 2.61
Debt/EBITDA 0.84
Cap/Depr 74.39%
Cap/Sales 1.44%
Interest Coverage 11.42
Cash Conversion 83.14%
Profit Quality 129.02%
Current Ratio 1.1
Quick Ratio 0.81
Altman-Z 3.69
F-Score7
WACC6.65%
ROIC/WACC1.46
Cap/Depr(3y)70.12%
Cap/Depr(5y)76.46%
Cap/Sales(3y)1.08%
Cap/Sales(5y)1.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)171.25%
EPS 3Y40.88%
EPS 5Y14.71%
EPS Q2Q%440%
EPS Next Y117.81%
EPS Next 2Y51.7%
EPS Next 3Y32.03%
EPS Next 5YN/A
Revenue 1Y (TTM)8.76%
Revenue growth 3Y0.93%
Revenue growth 5Y2.2%
Sales Q2Q%15.97%
Revenue Next Year16.61%
Revenue Next 2Y6.93%
Revenue Next 3Y5.13%
Revenue Next 5YN/A
EBIT growth 1Y85.53%
EBIT growth 3Y24.06%
EBIT growth 5Y0.93%
EBIT Next Year198.79%
EBIT Next 3Y47.18%
EBIT Next 5YN/A
FCF growth 1Y54%
FCF growth 3Y40.78%
FCF growth 5Y-6.65%
OCF growth 1Y39.25%
OCF growth 3Y8.69%
OCF growth 5Y-6.1%